| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine
|
Undevia, S.D.
|
|
|
15 |
11 |
p. 1705-1711
|
artikel
|
| 2 |
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients
|
Teruya-Feldstein, J.
|
|
|
15 |
11 |
p. 1673-1679
|
artikel
|
| 3 |
Chemotherapy for patients with hormone-refractory prostate cancer
|
Joly, F.
|
|
|
15 |
11 |
p. 1582-1584
|
artikel
|
| 4 |
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma
|
Wöhrer, S.
|
|
|
15 |
11 |
p. 1680-1683
|
artikel
|
| 5 |
Comments on “Expression of Cox-2 protein in radioresistant laryngeal cancer” (Ann Oncol 2004; 15: 1721)
|
Nix, P.
|
|
|
15 |
11 |
p. 1721-1722
|
artikel
|
| 6 |
Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease
|
Munker, R.
|
|
|
15 |
11 |
p. 1699-1704
|
artikel
|
| 7 |
Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells
|
Menendez, J.A.
|
|
|
15 |
11 |
p. 1719-1721
|
artikel
|
| 8 |
Expression of Cox-2 protein in radioresistant laryngeal cancer
|
Yalcin, B.
|
|
|
15 |
11 |
p. 1721
|
artikel
|
| 9 |
Fatigue in Cancer
|
Tirelli, U.
|
|
|
15 |
11 |
p. 1725
|
artikel
|
| 10 |
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
|
Yeo, W.
|
|
|
15 |
11 |
p. 1661-1666
|
artikel
|
| 11 |
Insurance for independent cancer trials
|
Perrone, F.
|
|
|
15 |
11 |
p. 1722-1723
|
artikel
|
| 12 |
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
|
Lorent, N.
|
|
|
15 |
11 |
p. 1645-1653
|
artikel
|
| 13 |
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy
|
Schneeweiss, A.
|
|
|
15 |
11 |
p. 1627-1632
|
artikel
|
| 14 |
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies
|
Colleoni, M.
|
|
|
15 |
11 |
p. 1633-1639
|
artikel
|
| 15 |
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
|
Grobmyer, S.R.
|
|
|
15 |
11 |
p. 1667-1672
|
artikel
|
| 16 |
Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer
|
Vischioni, B.
|
|
|
15 |
11 |
p. 1654-1660
|
artikel
|
| 17 |
Once-weekly dosing of recombinant human erythropoietin alpha in patients with myelodysplastic syndromes unresponsive to conventional dosing
|
Stasi, R.
|
|
|
15 |
11 |
p. 1684-1690
|
artikel
|
| 18 |
Palliative chemotherapy for advanced gastric cancer
|
Wöhrer, S.S.
|
|
|
15 |
11 |
p. 1585-1595
|
artikel
|
| 19 |
Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature
|
Chouliara, Z.
|
|
|
15 |
11 |
p. 1596-1602
|
artikel
|
| 20 |
Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer
|
Abratt, R.P.
|
|
|
15 |
11 |
p. 1613-1621
|
artikel
|
| 21 |
Recommendations for a Global Core Curriculum in Medical Oncology
|
Hansen, H.H.
|
|
|
15 |
11 |
p. 1603-1612
|
artikel
|
| 22 |
Risk factors for brain relapse in patients with metastatic breast cancer
|
Slimane, K.
|
|
|
15 |
11 |
p. 1640-1644
|
artikel
|
| 23 |
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study
|
Brugger, W.
|
|
|
15 |
11 |
p. 1691-1698
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
15 |
11 |
p. v-vi
|
artikel
|
| 25 |
Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?
|
Erman, M.
|
|
|
15 |
11 |
p. 1622-1626
|
artikel
|
| 26 |
t(14;18) and bcl-2 should not be used synonmously
|
Frickhofen, N.
|
|
|
15 |
11 |
p. 1723
|
artikel
|
| 27 |
The Entente Cordiale—natural and necessary
|
Kerr, D.J.
|
|
|
15 |
11 |
p. 1581
|
artikel
|
| 28 |
Trends in cancer mortality in Mexico, 1970–1999
|
Malvezzi, M.
|
|
|
15 |
11 |
p. 1712-1718
|
artikel
|
Tijdschrift beschrijving